This research demonstrates enhanced polyketide yields in Streptomyces through enzyme engineering and medium composition adjustments.
The objective of this study was to enhance the production of monensin and its derivatives in Streptomyces sp. ATCC 15413. To this end the contributions of medium composition and enzyme engineering on polyketide biosynthesis were assessed. Enzyme engineering was implemented through a single-point mutation in KS5 of the polyketide synthase (PKS). This mutation increased premonensin productivity up to 27-fold, revealing and alleviating a rate limiting step in the multi enzyme biosynthetic pathway. Medium optimization proved comparably effective, raising titers by at least an order of magnitude across strains. Moreover, medium optimization and ketosynthase mutagenesis acted additively in the premonensin strain, further boosting its production. Overall, our findings show that medium optimization is the dominant factor in maximizing monensin yields, while enzyme engineering can deliver targeted benefits in specific contexts.
No takes yet. Share an insight, caveat, or question.
Bravo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: